scispace - formally typeset
G

Giacomo Salvadore

Researcher at Janssen Pharmaceutica

Publications -  27
Citations -  1231

Giacomo Salvadore is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Sirukumab & Dementia. The author has an hindex of 11, co-authored 27 publications receiving 866 citations. Previous affiliations of Giacomo Salvadore include ACADIA Pharmaceuticals Inc. & Johnson & Johnson.

Papers
More filters
Journal ArticleDOI

Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis

Toby Wise, +45 more
- 01 Oct 2017 - 
TL;DR: The results suggest that MDD and BD are characterised by both common and distinct patterns of grey-matter volume changes, which has the potential to inform the development of diagnostic biomarkers for these conditions.
Journal ArticleDOI

Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions

TL;DR: A critical overview of the knowledge gaps about the use of ketamine in depression is provided and some future research directions for the investigation of ketamines as a promising tool to develop novel more effective and fast acting antidepressants are suggested.
Journal ArticleDOI

The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman’s disease

TL;DR: The data together suggest that the IL-6 antibodies improve depressive symptoms in patients with rheumatoid arthritis and MCD through improving primary disease dependent and independent mechanisms and the brain mechanisms underlying depressive symptom improvements.